切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2017, Vol. 11 ›› Issue (01) : 10 -14. doi: 10.3877/cma.j.issn.1674-3903.2017.01.003

所属专题: 经典病例 文献

论著

亲属活体供肾小肾癌切除后肾移植一例并文献复习
王继纳1, 郑龙1, 贾亦臣1, 戚贵生1, 许明1, 戎瑞明1, 朱同玉1,()   
  1. 1. 200032 上海,复旦大学附属中山医院泌尿外科 上海市器官移植重点实验室
  • 收稿日期:2016-07-27 出版日期:2017-02-25
  • 通信作者: 朱同玉
  • 基金资助:
    复旦大学附属中山医院优秀青年计划(2015ZSYXQN07)

Living related donor kidney transplantation after resection of a small renal cancer: case report and review of the literature

Jina Wang1, Long Zheng1, Yichen Jia1, Guisheng Qi1, Ming Xu1, Ruiming Rong1, Tongyu Zhu1,()   

  1. 1. Department of Urology, Zhongshan Hospital, Fudan University, Shanghai Key Laboratory of Organ Transplantation, Shanghai 20032, China
  • Received:2016-07-27 Published:2017-02-25
  • Corresponding author: Tongyu Zhu
  • About author:
    Corresponding author: Zhu Tongyu, Email:
引用本文:

王继纳, 郑龙, 贾亦臣, 戚贵生, 许明, 戎瑞明, 朱同玉. 亲属活体供肾小肾癌切除后肾移植一例并文献复习[J/OL]. 中华移植杂志(电子版), 2017, 11(01): 10-14.

Jina Wang, Long Zheng, Yichen Jia, Guisheng Qi, Ming Xu, Ruiming Rong, Tongyu Zhu. Living related donor kidney transplantation after resection of a small renal cancer: case report and review of the literature[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2017, 11(01): 10-14.

目的

总结亲属活体供肾小肾癌切除后肾移植相关要点和经验。

方法

回顾性分析2016年1月复旦大学附属中山医院1例亲属活体供肾小肾癌切除后肾移植的临床资料及术后转归。供者为受者母亲,供肾切取术前CT血管造影示右肾下极有一16 mm×15 mm类圆形病灶,考虑右肾小肾癌。经腰十一肋下小切口开放切取供者右肾,供肾切取后进行灌注冲洗,灌注满意后完整切除肿瘤并缝合创面,切除的肿瘤送术中冰冻病理检查,确定无边缘累及后行肾移植术。

结果

供肾小肾癌术后病理诊断为透明细胞癌,癌组织未侵犯肾被膜。供、受者术后均恢复良好,分别于术后第7、10天出院。受者术中移植肾血流开放前和术后第4天分别应用巴利昔单抗进行诱导治疗,术后3个月内免疫抑制方案为他克莫司+吗替麦考酚酯+醋酸泼尼松,3个月后将他克莫司调整为雷帕霉素。受者术后接受常规随访检查,同时每月接受移植肾彩超检查。截至2016年7月已随访6个月,随访期间移植肾彩超检查未见移植肾占位性病变,移植肾功能稳定。

结论

通过严格的供肾肿瘤评估及病理学确认,供肾小肾癌切除后可以行活体肾移植,且临床疗效和安全性较好,可作为扩大供肾来源的一种有效途径。

Objective

To summarize the experience and key points of living relative kidney transplantation after resection of a small renal cancer.

Methods

Retrospective analysis was performed on the clinical data and postoperative outcome of a case of living relative kidney transplantation after resection of a small cancer January 2016 in Zhongshan Hospital, Fudan University. The donor was the mother of recipient, CT angiography showed that there was a round spot (16 mm×15 mm) on the bottom of right kidney which was thought to be small renal carcinoma. Donor kidney was harvested through 11th-rib supracostal incision. Then it was washed and perfused with preservation solution. The tumor in the living donor kidney was resected and sent for intra-operational pathological examination and the tumor-resected kidney was subsequently used for kidney transplantation after no edge infiltration was confirmed.

Results

Post-operative pathological examination showed that the histologic type of the tumor was clear cell carcinoma and no carcinoma tissue was found in renal capsule. Basiliximab was used to immunosuppression induction before bloodstream was opened intranperative and 4 days after operation. The immunosuppressive therapy included tacrolimus+ mycophenolate+ prednisolone in 3 months after operation and tacrolimus switched to rapamycin later. Besides the regulatory examination, the recipient also received doppler ultrasound examination. The recipient was followed for 6 months until July 2016. No space-occupying lesion was found during follow-up and the function of the transplant kidney was stable.

Conclusions

With strict assessment and pathological confirmation, donor kidneys with a small cancer, once resected, can serve as a donor kidney in transplantation with good expectations. This may become an effective approach in increasing the source of donor kidney.

图1 亲属活体供肾小肾癌切除后肾移植供者供肾切取术前肾脏CT血管造影检查结果
图2 供肾小肾癌切除
图3 亲属活体供肾小肾癌切除后肿瘤组织术中冰冻病理检查结果(HE ×200)
图4 移植肾血管开放后状态
图5 亲属活体供肾小肾癌切除后肾移植供肾肿瘤及正常组织术后病理检查结果(HE ×200)
图6 亲属活体供肾小肾癌切除后肾移植受者术后第9天腹部+盆腔CT平扫结果
1
Heldal K,Hartmann A,Grootendorst DC, et al. Benefit of kidney transplantation beyond 70 years of age[J]. Nephrol Dial Transplant, 2010, 25(5): 1680-1687.
2
Yu N,Fu S,Fu Z, et al. Allotransplanting donor kidneys after resection of a small renal cancer or contralateral healthy kidneys from cadaveric donors with unilateral renal cancer: a systematic review[J]. Clin Transplant, 2014, 28(1): 8-15.
3
高宏君,罗向东,梁泰生, 等. 经背腰十二肋小切口活体供肾37例:安全性效果评价[J]. 中国组织工程研究与临床康复, 2010, 14(53): 9991-9994.
4
Penn I. Primary kidney tumors before and after renal transplantation[J]. Transplantation, 1995, 59(4): 480-485.
5
Buell JF,Hanaway MJ,Thomas M, et al. Donor kidneys with small renal cell cancers: can they be transplanted?[J]. Transplant Proc, 2005, 37(2): 581-582.
6
Desai R,Collett D,Watson CJ, et al. Cancer transmission from organ donors-unavoidable but low risk[J]. Transplantation, 2012, 94(12): 1200-1207.
7
Delmonico F,Council of the Transplantation Society. A report of the amsterdam forum on the care of the live kidney donor: data and medical guidelines[J]. Transplantation, 2005, 79(6 Suppl): S53-S66.
8
Nalesnik MA,Woodle ES,Dimaio JM, et al. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk[J]. Am J Transplant, 2011, 11(6): 1140-1147.
9
Kälble T,Lucan M,Nicita G, et al. EAU guidelines on renal transplantation[J]. Eur Urol, 2005, 47(2): 156-166.
10
Sener A,Uberoi V,Bartlett ST, et al. Living-donor renal transplantation of grafts with incidental renal masses after ex-vivo partial nephrectomy[J]. BJU Int, 2009, 104(11): 1655-1660.
11
Richstone L,Scherr DS,Reuter VR, et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival[J]. J Urol, 2004, 171(2): 615-620.
[1] 邹永康, 石雍, 徐贤刚, 张帅民, 刘衍, 杨生鹏, 叶啟发, 陈根, 张毅. 肾移植术后手术切口米根霉感染伴菌血症一例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 289-292.
[2] 中华医学会器官移植学分会. 遗体捐献肾脏获取手术技术操作指南[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 257-265.
[3] 吕玥彤, 靳梦圆, 周大为, 叶啟发. 机器人辅助下肾移植的临床进展与争议[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 242-246.
[4] 尚丽红, 王志华, 张文艳, 朱琳茹, 周华. 内皮粘蛋白抗体与肾移植术后抗体介导排斥反应和移植肾预后的研究[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 165-170.
[5] 吕军好, 林锦雯, 张心怡, 陈江华. 细胞外囊泡在肾移植诊断和治疗中的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 186-192.
[6] 郭明星, 徐烨, 徐菀佚, 赵莹, 刘冉佳, 潘晨, 崔向丽. 2017—2022年中国105家医院肾移植术后门诊受者免疫抑制剂用药分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 104-109.
[7] 陆婷, 陈浩, 王雪静, 谭若芸, 彭宇竹. 肾移植术后一年发生代谢综合征的危险因素分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 98-103.
[8] 张心怡, 吕军好, 陈大进. 2023年肾移植领域研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 7-11.
[9] 吴小山, 任桂灵, 朱杰东, 史天陆, 马葵芬. 肾移植受者围手术期霉酚酸暴露量及不良反应分析[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 17-21.
[10] 赵丽, 蔡瑞明, 赵纪强, 林民专, 陈志勇, 彭娟. 肾移植术后新发泌尿系统恶性肿瘤二例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 35-39.
[11] 陆婷, 姜巧玲, 孙黎, 王雪静. 加速康复外科在肾移植围手术期应用的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 55-59.
[12] 张超, 过菲, 王富博, 叶宸, 杨悦, 杨波. 腹腔镜肾部分切除术:肾癌合并肾静脉癌栓的新选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 219-224.
[13] 朱显钟, 李金雨, 于忠英, 温路生. 淋巴结平均直径与无淋巴结转移肾癌病理特征及预后关系研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 146-151.
[14] 张秋玥, 程羽, 牛雨田, 唐茂芝, 张克勤, 张懿, 郭亚楠, 涂增. 肾移植与人体微生态的相关性研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 207-213.
[15] 余旭旭, 魏杰, 楼芳. 卵巢透明细胞癌诊疗现状及进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(01): 91-95.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?